Oppenheimer Reiterates Outperform Rating on Protera Therapeutics (TARA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq hits record high as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| (NASDAQ: TARA) | Delayed: 2.62 -0.08 (2.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.70 | 52 Week High | $ | |||
| Open | $2.71 | 52 Week Low | $ | |||
| Day High | $2.72 | P/E | N/A | |||
| Day Low | $2.57 | EPS | $ | |||
| Volume | 947,130 | |||||
